Participated · Series B · Jul 2020

Geltor operates an Ingredients-as-a-Service™ platform that designs and produces designer proteins with biocompatibility and functionality for consumer products. Its products are 100% animal-free, sustainably cultivated, and clinically demonstrated for high performance. The company has applied its biodesign technology across global CPG segments including cosmetics & personal care, nutraceuticals, and food & beverage. Geltor closed a $91.3M Series B to support its growth. The company intends to use the proceeds to expand the global footprint of its platform and to accelerate demand from global CPG companies for sustainable, functional, animal-free ingredients. Its technology emphasizes sustainability and performance for large and growing consumer markets. Geltor is a bio-design company that creates designer proteins, starting with collagen, using a sustainable fermentation process. The company produces 100% animal- and GMO-free proteins and markets a clinically-tested vegan collagen called N-Collage. N-Collage is positioned to deliver cellular regeneration, protection and derma-collagen synthesis and is Certified Halal. Geltor raised $18.2m in a Series A financing and intends to use the proceeds to expand its product offering of animal- and GMO-free proteins. Founded in 2015 by Alexander Lorestani and Nick Ouzounov and based in San Leandro, CA, the company combines bio-design and fermentation to replace animal-derived ingredients. The Series A increased the company’s total funding to $23m.